-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, KCnKfajb1zzThYoY6BheqnrAa3Nzbj+cl67kkRZcYH+upSNrBB9HEOCMp9QL2GrR AzaT32rOMt+PeTImDCvoTQ== 0001005477-99-004889.txt : 19991029 0001005477-99-004889.hdr.sgml : 19991029 ACCESSION NUMBER: 0001005477-99-004889 CONFORMED SUBMISSION TYPE: POS AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19991028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TRIANGLE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001022622 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 561930728 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: POS AM SEC ACT: SEC FILE NUMBER: 333-44881 FILM NUMBER: 99735672 BUSINESS ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 9194935980 MAIL ADDRESS: STREET 1: 4 UNIVERSITY PLACE STREET 2: 4611 UNIVERSITY DRIVE CITY: DURHAM STATE: NC ZIP: 27707 POS AM 1 AMENDMENT NO. 1 TO FORM S-3 AS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION ON OCTOBER 28, 1999 REGISTRATION NO. 333-44881 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 ------------- POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-3 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 TRIANGLE PHARMACEUTICALS, INC. (Exact name of Registrant as Specified in Its Charter) DELAWARE 56-1930728 (State or Other Jurisdiction (I.R.S. Employer of Incorporation or Organization) Identification No.) 4 UNIVERSITY PLACE 4611 UNIVERSITY DRIVE DURHAM, NORTH CAROLINA, 27707 (919) 493-5980 (Address, Including Zip Code and Telephone, Including Area Code, of Registrant's Principal Executive Offices) DAVID W. BARRY, M.D. CHAIRMAN AND CHIEF EXECUTIVE OFFICER TRIANGLE PHARMACEUTICALS, INC. 4 UNIVERSITY PLACE, 4611 UNIVERSITY DRIVE DURHAM, NORTH CAROLINA, 27707, (919) 493-5980 (Name, Address, Including Zip Code and Telephone Number, Including Area Code, of Agent for Service) Copies To: ELLEN B. CORENSWET, ESQ. LUCI STALLER ALTMAN, ESQ. BROBECK, PHLEGER & HARRISON LLP 1633 BROADWAY, 47TH FLOOR NEW YORK, NEW YORK 10019 (212) 581-1600 - -------------------------------------------------------------------------------- - -------------------------------------------------------------------------------- DEREGISTRATION OF SHARES Triangle amends this Registration Statement on Form S-3 (Reg. No. 333-44881) to deregister and remove from registration 2,789,500 shares of Triangle's Common Stock remaining unsold at the conclusion of the offering described in the registration statement. The shares were being offered by certain selling stockholders of Triangle. SIGNATURES Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-3 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Durham, State of North Carolina, on the 28th day of October, 1999. TRIANGLE PHARMACEUTICALS, INC. By: /s/ DAVID W. BARRY ----------------------------------------- David W. Barry CHAIRMAN AND CHIEF EXECUTIVE OFFICER Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated: SIGNATURE TITLE - --------------------------- -------------------------- Chairman of the Board and /s/ DAVID W. BARRY Chief Executive Officer - --------------------------- (Principal Executive Officer) October 28, 1999 David W. Barry Acting Chief Financial /s/ THOMAS R. STAAB II Officer and Treasurer - --------------------------- (Principal Financial October 28, 1999 Thomas R. Staab II and Accounting Officer) * - --------------------------- Director and President October 28, 1999 M. Nixon Ellis * - --------------------------- Director October 28, 1999 Anthony B. Evnin * - --------------------------- Director October 28, 1999 Standish M. Fleming - --------------------------- Director October ___, 1999 Dennis B. Gillings - --------------------------- Director October ___, 1999 Henry G. Grabowski - --------------------------- Director October ___, 1999 Arthur J. Higgins * - --------------------------- Director October 28, 1999 George McFadden *By: /s/ DAVID W. BARRY - --------------------------- David W. Barry ATTORNEY-IN-FACT -----END PRIVACY-ENHANCED MESSAGE-----